---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-25-000117"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:57:24.557261+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Maravai Q3 revenue $41.6M, net loss $45.1M, Adj EBITDA -$10.8M

## Summary
- Revenue of $41.6 million, net loss of $45.1 million, and Adjusted EBITDA loss of $10.8 million for Q3 2025.
- Full-year 2025 revenue guidance of approximately $185 million, excluding potential high-volume CleanCap orders.
- CEO expects double-digit sequential revenue growth in Q4 2025, citing strong funnel and order velocity at TriLink.
- Organizational restructuring and operating cost reduction initiatives remain on track.

## SEC filing metadata
- accession: 0001823239-25-000117
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000117/0001823239-25-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000117/mrvi-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-25-000117
- JSON: https://secwatch.observer/filing/0001823239-25-000117.json
- Plain text: https://secwatch.observer/filing/0001823239-25-000117.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.